ARCHIVES

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

Obama Lifts Ban on Federal Funding for Embryonic Stem Cell Research, Signs Memo on Scientific Integrity

March 13, 2009

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997

CCOP Wins Vote Of Confidence From NCI Advisors

November 12, 2010

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991